About BioNTech BioNTech is a global next generation biopharmaceutical company pioneering novel investigative therapies for cancer and other serious diseases. In oncology, BioNTech is committed to ...
Late-breaking oral presentation will feature first data from the global ROSETTA Lung-107 Phase 2 clinical trial evaluating pumitamig, a ...
BioNTech presents promising lung cancer drug data at ELCC 2026, but investor sentiment remains cautious due to revenue forecast and high pipeline stakes. The European Lung Cancer Congress 2026 in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
Why is BioNTech stock gaining Monday?
On Monday, BioNTech SE BNTX and OncoC4 Inc. released the first median overall survival results from stage 1 of their global PRESERVE-003 Phase 3 trial. The data indicate their investigational therapy ...
BioNTech shares rally 24% on Moderna's cancer vaccine success, but investors await pivotal lung cancer data in September. The numbers look almost contradictory on paper. Revenue collapsed 76 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results